1 / 9

Global anticancer drugs market - Industry Trends & Forecast Report 2027

The global anticancer drugs market was worth USD 112.3 billion in 2020 and is further projected to reach USD 175.9 billion by the year 2027, growing at a CAGR of 6.9% in the forecast period

25321
Télécharger la présentation

Global anticancer drugs market - Industry Trends & Forecast Report 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Flourishing Advancement of Global Anticancer Drugs Market: Projected to Grow at a CAGR of 6.9% During the Forecast Period Global anticancer drugs market - Industry Trends & Forecast Report 2027 View report Sample report Press release Global Anticancer Drugs Market, By Drug Class (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs), By Therapy (Chemotherapy, Immunotherapy), By Indication (Lung Cancer, Breast Cancer, Stomach Cancer, Colorectal Cancer, Prostate Cancer, Others), By Dosage Form (Solid, Liquid, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Others), By Region (North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle-East & Africa (MEA) Trend Analysis, Competitive Market Share & Forecast, 2017-2027. A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the global anticancer drugs market was worth USD 112.3 billion in the year 2020. The data yielded by the report further states that the market is estimated to grow at a CAGR of 6.9%, earning revenue of around USD 175.9 billion by the end of 2027. The global anticancer drugs market is flourishing at a high rate because of the increasing prevalence of cancer worldwide and growing research and development activities for advancing anticancer drugs. Nevertheless, the adverse side effects of the anticancer drugs may harm the market revenue up to some degree. Targeted Therapy, Report Overview The global anticancer drugs market is growing at a high rate due to the increasing prevalence of various types of cancer and expanding research and

  2. Flourishing Advancement of Global Anticancer Drugs Market: Projected to Grow at a CAGR of 6.9% During the Forecast Period development activities for improving and increasing the effectiveness of anticancer drugs. The global anticancer drugs market was worth USD 112.3 billion in 2020 and is further projected to reach USD 175.9 billion by the year 2027, growing at a CAGR of 6.9% in the forecast period. The market is growing at a high rate due to the increasing prevalence of various types of cancer. Worldwide, cancer has been estimated to cause 19.3 million cases in 2020 and 10 million deaths.Furthermore, the increased effort to improve and enhance the effectiveness of anticancer drugs is also driving the growth of the global anticancer drugs market. Source: BlueWeave Consulting Global Anticancer Drugs Market- Overview Anticancer drugs are medications which are effective in the treatment of malignant and cancerous diseases. They are also known as antineoplastic drugs. Currently, the most common cancer therapy is Celgene's Revlimid (lenalidomide), which has proven to be very successful in treating multiple myeloma due to its ability to improve immune responses and decelerate tumor growth.Other common anticancer drugs are Altretamine, Temozolomid, Mechlorethamine, Procarbazine, Carmustine. Global Anticancer Drugs Market Forecast and Trends Growth Drivers Increasing Prevalence of Various Types of Cancer The prevalence of cancer is increasing at a very high rate. It has been estimated that there were more than 19.3 million cases and 10 million deaths worldwide due to cancer.The International Agency for Research on Cancer (IARC) estimates that 17.0 million new cases of cancer were diagnosed in 2018 and 9.5 million cancer

  3. Flourishing Advancement of Global Anticancer Drugs Market: Projected to Grow at a CAGR of 6.9% During the Forecast Period deaths occurred globally. Furthermore, the global burden of cancer is expected to rise to 27.5 million new cases and 16.3 million cancer deaths by 2040. Because of the high prevalence of cancer, there is a surge in demand for anticancer drugs for the treatment of various types of cancer, which in turn is propelling the global anticancer drugs market forward. Expanding R&D Activities Favoringthe Development of Anticancer Drugs Cancer is a very advanced and complex disease, so its treatment necessitates the use of multifunctional drugs that are effective in controlling the disease.Therefore, the pharmaceutical and biotechnology companies constantly engage themselves in R & D activities for advancing anticancer drugs. For instance, research institutes are working towards the development of hybrid anticancer drugs. Hybrid compounds have more than a single target which proves to be more effective in destroying cancer cells. Anticancer drugs market is expected to flourish in upcoming years, as a result of such research activities Restraints Adverse Side Effects of Anticancer Drugs Despite high demand for anticancer drugs, the adverse long-term side effects they have on patients cannot be ignored.The cancer patients receiving targeted therapy, chemotherapy, or other types of therapies often experience side effects such as diarrhea, fatigue, edema (swelling), nausea, vomiting, etc. In addition to bruising and bleeding, cancer drugs can increase the risk of infection and breathlessness.In order to minimize these effects, the researchers are working hard, but they are still far from succeeding.Thus, the side effects of cancer treatment may is impeding the growth of the anticancer drugs market. Impact of COVID-19 on Global Anticancer Drugs Market With the sudden onset of COVID-19, hospitals were faced with unprecedented challenges.The COVID-19-induced pandemic has been a significant drain on health care resources as well as professionals.Due to this, the diagnosis and treatment of many other diseases were postponed or put on hold. However, this situation presented significant growth opportunities for the global anticancer drug market.This is because the cancer patientsavoided visiting hospitals facilities as they were most susceptible to transmission of COVID-19. This in turn proliferated the overall market growth because of their reliance on anticancer drugs to control cancer cells. Global Anticancer Drugs Market - By Drug Class Based on drug class, the global anticancer drugs market is segmented into cytotoxic drugs, targeted drugs, and hormonal drugs. Due to the high adoption of targeted therapy for cancer treatment, the targeted drug segment accounts for the largest market share.Compared to chemotherapy, target therapy has fewer

  4. Flourishing Advancement of Global Anticancer Drugs Market: Projected to Grow at a CAGR of 6.9% During the Forecast Period side effects because it doesn't attack healthy cells and prompts the body's immune system to attack the cancer cells. Because of this, R&D activities in anticancer drug research are more closely focused on developing targeted drugs. Global Anticancer Drugs Market - By Indication Based on indications, the global anticancer drugs market is segmented into lung cancer, breast cancer, stomach cancer, colorectal cancer, prostate cancer, and others. The breast cancer segment accounts for the largest share of this market since it is the most prevalent type of cancer, surpassing lung cancer. According to the WHO, 2.3 million women diagnosed with breast cancer in 2020 and it led to 685,000 deaths worldwide. Furthermore, the increasing awareness of breast cancer is also driving the demand for diagnostic tests, which further drives the demand for anticancer drugs. Global Anticancer Drugs Market - Regional Insights Geographically, the global anticancer drugs market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa. Among these regions, North America dominates the market due to the high prevalence of cancer in countries like the US and Canada and the increasing diagnostic tests for cancer types like breast cancer. According to estimates, there are 1.9 million cancer cases in Northern America of which breast cancer, lung cancer, and prostate cancer affect a significant percentage of the population. As a result, the demand for anticancer drugs is flourishing at a high rate in this region. Source: BlueWeave Consulting Competitive Landscape The leading market players in the global anticancer drugs market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Pfizer Inc., Novartis AG, Merck & Co. Inc., Bristol-Myers Squibb Company, AstraZeneca PLC, Astellas Pharma Inc., AbbVie

  5. Flourishing Advancement of Global Anticancer Drugs Market: Projected to Grow at a CAGR of 6.9% During the Forecast Period Inc., Amgen, Takeda Oncology Drugs Ltd., GlaxoSmithKline, Sanofi, Celgene Corporation, Boehringer Ingelheim GmbH, Teva Pharmaceuticals, Eli Lilly and Company, Millennium Pharmaceuticals, Kolaz Biotech, and other prominent players. The industry participants invest heavily in the R&D activities for product approvals and launches to stay ahead in the competition. They also offer a wide range of products to various geographical locations to expand their market revenue share. Furthermore, the adoption of competitive strategies like partnerships, mergers, collaborations, joint ventures is also very prominent in this market. Recent Development In July 2021, GenFleet Therapeutics, a Chinese biotech company, and Insilico Medicine, a Hongkong-based biotechnology company, announced their strategic partnership for advancing novel therapies and addressing unmet medical needs in cancer therapeutics.  In February 2021, Cend Therapeutics, a US-based biotechnology company, and Qilu Pharmaceutical, a Chinese Pharmaceutical Company, announced their collaboration and license agreement to commercialize Cend’s cancer treatment to China.  Scope of the Report Attributes Details Historical data – 2017-2020 Years Considered Base Year – 2020 Forecast – 2021 – 2027 Facts Covered Revenue in USD Million U.S, Canada, Germany, UK, France, Italy, Spain, Brazil, Mexico, Japan, South Korea, China, India, UAE, South Africa, Saudi Arabia Market Coverage

  6. Flourishing Advancement of Global Anticancer Drugs Market: Projected to Grow at a CAGR of 6.9% During the Forecast Period By Drug Class, By Therapy, By Indication, By Dosage Form, By Distribution Channel, By Region Product Service/Segmentation Johnson & Johnson, F. Hoffmann-La Roche Ltd., Pfizer Inc., Novartis AG, Merck & Co. Inc., Bristol-Myers Squibb Company, AstraZeneca PLC, Astellas Pharma Inc., AbbVie Inc., Amgen, Takeda Oncology Drugs Ltd., GlaxoSmithKline, Sanofi, Celgene Corporation, Ingelheim GmbH, Teva Pharmaceuticals, Eli Lilly and Company, Millennium Pharmaceuticals, Kolaz Biotech, and other prominent players. Key Players Boehringer By Drug Class Cytotoxic Drugs  1.Alkylating Agents 2.Antimetabolites 3.Others Targeted Drugs  1.Monoclonal Antibodies 2.Others Hormonal Drugs  By Therapy Chemotherapy Targeted Therapy Immunotherapy    By Indication Lung Cancer Breast Cancer Stomach Cancer Colorectal Cancer Prostate Cancer Others      

  7. Flourishing Advancement of Global Anticancer Drugs Market: Projected to Grow at a CAGR of 6.9% During the Forecast Period By Dosage Form Solid  1.Tablets 2.Capsules Liquid Injectable   1.Prefilled Syringes 2.others By Distribution Channel Hospital Pharmacies Retail Pharmacies Online Others     By Region North America Europe Asia-Pacific (APAC) Latin America (LATAM) Middle-East & Africa (MEA)      FAQs: 1. What is the current size of the global anticancer drugs market? Answer: The global anticancer drugs market reached USD 112.3 billion in 2020. 2. What are the major factors driving the growth of the global anticancer drugs market? Answer: The major factors driving the growth of the global anticancer drugs market are; increasing prevalence of various types of cancer and expanding r&d activities in the development of anticancer drugs. 3. Who are the key players in the global anticancer drugs market? Answer: The key players in the global anticancer drugs market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Pfizer Inc., Novartis AG, Merck & Co. Inc., Bristol-Myers Squibb Company, AstraZeneca PLC, Astellas Pharma Inc., AbbVie Inc., Amgen, Takeda Oncology Drugs Ltd., GlaxoSmithKline, Sanofi, Celgene Corporation, Boehringer Ingelheim GmbH, Teva Pharmaceuticals, Eli Lilly and Company, Millennium Pharmaceuticals, Kolaz Biotech, and other prominent players.

  8. Flourishing Advancement of Global Anticancer Drugs Market: Projected to Grow at a CAGR of 6.9% During the Forecast Period 4. Which therapy segment accounted for the largest share in the global anticancer drugs market? Answer: The targeted therapy segment accounted for the largest share in the global anticancer drugs market. 5. Which region is at the highest growth rate in the global anticancer drugs market? Answer: North America has the largest share in the global anticancer drugs market. About us Blueweave Consulting offers a one-stop solution for your market intelligence needs for any service or product. You get well-researched comprehensive reports based on qualitative and quantitative data to put your business plan into action. Your well informed and timely decisions using our reports avert situations of excessive risks and help you grow your business with optimum risk-return trade- off. Delivering quality insights into several product or service markets within the timeline as per the needs of the clients has earned BWC an excellent reputation among clients. BWC strives to provide timely and accurate digital market intelligence services for making your business endeavours successful. For more information, kindly visit our Website www.blueweaveconsulting.com contact us info@blueweaveconsulting.com

  9. Flourishing Advancement of Global Anticancer Drugs Market: Projected to Grow at a CAGR of 6.9% During the Forecast Period

More Related